NEXTGEN HEALTHCARE INC (NXGN) Stock Price, Quote, News and Overview
NASDAQ:NXGN - Nasdaq - US65343C1027 - Common Stock - Currency: USD
NXGN Quote, Performance and Key Statistics
23.94
+0.03 (+0.13%)
The current stock price of NXGN is 23.94 USD. In the past month the price increased by 0.55%. In the past year, price increased by 19.28%.
NXGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
| DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
| CERT | CERTARA INC | 33.77 | 2.12B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
| SDGR | SCHRODINGER INC | N/A | 1.65B | ||
| PHR | PHREESIA INC | N/A | 1.64B | ||
| EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
| HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
Related stock screener links
About NXGN
Company Profile
NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. The company is headquartered in Irvine, California and currently employs 2,783 full-time employees. Its portfolio includes integrated solutions, which delivers on ambulatory healthcare imperatives, including consumerism, digitization, risk allocation, regulatory influence, and integrated care and health equity. Its solutions deliver care in various medical specialty in a range of practice models, including accountable care organizations (ACOs), independent physician associations (IPAs), managed service organizations (MSOs), veterans service organizations (VSOs) and dental service organizations. The company offers services across enterprise, office and insights, which include NextGen Enterprise HER, NextGen Enterprise PM, NextGen Virtual Visit, NextGen Office, NextGen Share and Mirth Connect. The company also offers data and analytics solutions, which include NextGen Health Data Hub.
Company Info
NEXTGEN HEALTHCARE INC
18111 Von Karman Avenue, Suite 600
Irvine CALIFORNIA 92612 US
CEO: John R. Frantz
Employees: 2783
Company Website: https://www.nextgen.com/
Phone: 19492552600.0
NEXTGEN HEALTHCARE INC / NXGN FAQ
What is the stock price of NEXTGEN HEALTHCARE INC today?
The current stock price of NXGN is 23.94 USD. The price increased by 0.13% in the last trading session.
What is the ticker symbol for NEXTGEN HEALTHCARE INC stock?
The exchange symbol of NEXTGEN HEALTHCARE INC is NXGN and it is listed on the Nasdaq exchange.
On which exchange is NXGN stock listed?
NXGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NEXTGEN HEALTHCARE INC stock?
13 analysts have analysed NXGN and the average price target is 24.41 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 23.94. Check the NEXTGEN HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEXTGEN HEALTHCARE INC worth?
NEXTGEN HEALTHCARE INC (NXGN) has a market capitalization of 1.61B USD. This makes NXGN a Small Cap stock.
How many employees does NEXTGEN HEALTHCARE INC have?
NEXTGEN HEALTHCARE INC (NXGN) currently has 2783 employees.
What are the support and resistance levels for NEXTGEN HEALTHCARE INC (NXGN) stock?
NEXTGEN HEALTHCARE INC (NXGN) has a support level at 23.9 and a resistance level at 23.95. Check the full technical report for a detailed analysis of NXGN support and resistance levels.
Is NEXTGEN HEALTHCARE INC (NXGN) expected to grow?
The Revenue of NEXTGEN HEALTHCARE INC (NXGN) is expected to grow by 11.2% in the next year. Check the estimates tab for more information on the NXGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEXTGEN HEALTHCARE INC (NXGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NXGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NXGN, evaluating the profitability, health, valuation and growth aspects
- NEXTGEN HEALTHCARE INC (NXGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEXTGEN HEALTHCARE INC (NXGN) Sales and EPS estimates to see what analysts future expectations are.
- NEXTGEN HEALTHCARE INC (NXGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEXTGEN HEALTHCARE INC (NXGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEXTGEN HEALTHCARE INC (NXGN) Stock Chart to make your own analysis
- NEXTGEN HEALTHCARE INC (NXGN) Latest news and press-releases to stay up to date.
Does NEXTGEN HEALTHCARE INC (NXGN) stock pay dividends?
NXGN does not pay a dividend.
When does NEXTGEN HEALTHCARE INC (NXGN) report earnings?
NEXTGEN HEALTHCARE INC (NXGN) will report earnings on 2024-01-22, after the market close.
What is the Price/Earnings (PE) ratio of NEXTGEN HEALTHCARE INC (NXGN)?
The PE ratio for NEXTGEN HEALTHCARE INC (NXGN) is 21.38. This is based on the reported non-GAAP earnings per share of 1.12 and the current share price of 23.94 USD. Check the full fundamental report for a full analysis of the valuation metrics for NXGN.
NXGN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NXGN. When comparing the yearly performance of all stocks, NXGN is one of the better performing stocks in the market, outperforming 94.01% of all stocks.
NXGN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NXGN. NXGN has only an average score on both its financial health and profitability.
NXGN Financial Highlights
Over the last trailing twelve months NXGN reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS increased by 33.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.72% | ||
| ROE | -1.47% | ||
| Debt/Equity | 0.63 |
NXGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 51% to NXGN. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 14.49% and a revenue growth 11.2% for NXGN